The company is developing UT Dallas research into novel drug treatments for people with limited options to treat their chronic pain. Brougher published his research in a scientific journal for the first time while working in Thorn’s lab. “Opiates mask the symptoms of pain but don’t directly target the underlying mechanisms of what’s causing pain,” Brougher said. Initially employing just the four co-founders, the company is expanding its research efforts and hiring staff and laboratory scientists. “Now I’m sitting in our office here at Doloromics and right outside is our lab, which is wild,” Brougher said.